Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients

Critical Care

Volumn 16, Issue 3, 2012, Pages

  Link, Andreas ^a   Klingele, Matthias ^a   Speer, Timo ^a   Rbah, Ranja ^a   Pöss, Janine ^a   Lerner Gräber, Anne ^a   Fliser, Danilo ^a   Böhm, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CITRATE TRISODIUM; HEPARIN; INDOCYANINE GREEN; ANTICOAGULANT AGENT; CALCIUM; CITRIC ACID;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULANT THERAPY; AREA UNDER THE CURVE; ARTICLE; BLEEDING; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CLINICAL ASSESSMENT; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; INCIDENCE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALIDITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STEADY STATE; TOTAL TO IONIZED CALCIUM RATIO; UREA NITROGEN BLOOD LEVEL; BLOOD; CRITICAL ILLNESS; MIDDLE AGED; PROCEDURES; RENAL REPLACEMENT THERAPY; TRENDS;

AGED; ANTICOAGULANTS; CALCIUM; CITRIC ACID; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY;

EID: 84861468522     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11363     Document Type: Article

References (32)

1. Bellomo R, Kellum J, Ronco C. Acute renal failure: time for consensus. Intensive Care Med 2001, 27:1685-1688. 10.1007/s00134-001-1120-6, 11810109.
2. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007, 2:431-439. 10.2215/CJN.03681106, 17699448.
3. Uchino S. The epidemiology of acute renal failure in the world. Curr Opin Crit Care 2006, 12:538-543. 10.1097/01.ccx.0000247448.94252.5a, 17077683.
4. Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002, 40:875-885. 10.1053/ajkd.2002.36318, 12407631.
5. Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, Pallot JL, Chiche JD, Taupin P, Landais P, Dhainaut JF. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006, 368:379-385. 10.1016/S0140-6736(06)69111-3, 16876666.
6. Ronco C. Continuous dialysis is superior to intermittent dialysis in acute kidney injury of the critically ill patient. Nat Clin Pract Nephrol 2007, 3:118-119. 10.1038/ncpneph0423, 17322924.
7. Oudemans-van Straaten HM, Wester JP, de Pont AC, Schetz MR. Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?. Intensive Care Med 2006, 32:188-202. 10.1007/s00134-005-0044-y, 16453140.
8. Tolwani AJ, Wille KM. Anticoagulation for continuous renal replacement therapy. Semin Dial 2009, 22:141-145. 10.1111/j.1525-139X.2008.00545.x, 19426417.
9. Durao MS, Monte JC, Batista MC, Oliveira M, Iizuka IJ, Santos BF, Pereira VG, Cendoroglo M, Santos OF. The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury. Crit Care Med 2008, 36:3024-3029. 10.1097/CCM.0b013e31818b9100, 18824904.
10. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009, 37:545-552. 10.1097/CCM.0b013e3181953c5e, 19114912.
11. Tolwani AJ, Palevsky PM. Introduction. The clinical application of CRRT--current status. Semin Dial 2009, 22:107. 10.1111/j.1525-139X.2008.00557.x, 19426411.
12. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, Gangl A. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003, 31:2450-2455. 10.1097/01.CCM.0000084871.76568.E6, 14530750.
13. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001, 29:748-752. 10.1097/00003246-200104000-00010, 11373461.
14. Nowak MA, Campbell TE. Profound hypercalcemia in continuous veno-venous hemofiltration dialysis with trisodium citrate anticoagulation and hepatic failure. Clin Chem 1997, 43:412-413.
15. Cote CJ, Goldstein EA, Fuchsman WH, Hoaglin DC. The effect of nail polish on pulse oximetry. Anesth Analg 1988, 67:683-686.
16. Díaz J, Acosta F, Parrilla P, Sansano T, Contreras RF, Bueno FS, Martínez P. Correlation among ionized calcium, citrate, and total calcium levels during hepatic transplantation. Clin Biochem 1995, 28:315-317. 10.1016/0009-9120(94)00094-C, 7554253.
17. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.1993.03510240069035, 8254858.
18. Geerts W, Selby R. Prevention of venous thromboembolism in the ICU. Chest 2003, 124:357S-363S. 10.1378/chest.124.6_suppl.357S, 14668418.
19. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133:381S-453S. 10.1378/chest.08-0656, 18574271.
20. Graafsma YP, Prins MH, Lensing AW, de Haan RJ, Huisman MV, Buller HR. Bleeding classification in clinical trials: observer variability and clinical relevance. Thromb Haemost 1997, 78:1189-1192.
21. Kimura S, Yoshioka T, Shibuya M, Sakano T, Tanaka R, Matsuyama S. Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Crit Care Med 2001, 29:1159-1163. 10.1097/00003246-200106000-00014, 11395594.
22. Sakka SG. Assessing liver function. Curr Opin Crit Care 2007, 13:207-214. 10.1097/MCC.0b013e328012b268, 17327744.
23. Sakka SG, Reinhart K, Wegscheider K, Meier-Hellmann A. Comparison of cardiac output and circulatory blood volumes by transpulmonary thermo-dye dilution and transcutaneous indocyanine green measurement in critically ill patients. Chest 2002, 121:559-565. 10.1378/chest.121.2.559, 11834672.
24. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990, 38:976-981. 10.1038/ki.1990.300, 2266683.
25. Egi M, Kim I, Nichol A, Stachowski E, French CJ, Hart GK, Hegarty C, Bailey M, Bellomo R. Ionized calcium concentration and outcome in critical illness. Crit Care Med 2011, 39:314-321. 10.1097/CCM.0b013e3181ffe23e, 21099425.
26. Hadique S, Khamare C, Finkel MS. The Frog Prince of calcium homeostasis. Crit Care Med 2011, 39:406-408. 10.1097/CCM.0b013e318205c34d, 21248524.
27. Whitted AD, Stanifer JW, Dube P, Borkowski BJ, Yusuf J, Komolafe BO, Davis RC, Soberman JE, Weber KT. A dyshomeostasis of electrolytes and trace elements in acute stressor states: impact on the heart. Am J Med Sci 2010, 340:48-53. 10.1097/MAJ.0b013e3181e5945b, 20610973.
28. Malcolm DS, Zaloga GP, Holaday JW. Calcium administration increases the mortality of endotoxic shock in rats. Crit Care Med 1989, 17:900-903. 10.1097/00003246-198909000-00012, 2504540.
29. Zaloga GP, Sager A, Black KW, Prielipp R. Low dose calcium administration increases mortality during septic peritonitis in rats. Circ Shock 1992, 37:226-229.
30. Swartz R, Pasko D, O'Toole J, Starmann B. Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation. Clin Nephrol 2004, 61:134-143.
31. Reichling JJ, Kaplan MM. Clinical use of serum enzymes in liver disease. Dig Dis Sci 1988, 33:1601-1614. 10.1007/BF01535953, 2904353.
32. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000, 6:163-169.